Update in Migraine Medication
Lecturer: Alicia Duyvejonck, ARNP, DNP https://app2app.org/ Join Alicia, our APP2APP Headache specialist, Program Director of the Headache Clinic in Genesis Health Care System in Davenport, IA, as she discusses the newest drugs on the market to treat Headache. Alicia will discuss new oral medications such as gepants, which target and reduce CGRP (calcitonin gene-related peptide) reducing inflammation, ditans (lasmiditan), new injections that have recently come to market, as well as the newest monoclonal antibody infusion that targets CGRP (eptinezumab). Please consider SUBSCRIBING to our YouTube page to help us continue to help our colleagues!

▶︎
COVID Headache

▶︎
An Update in Migraine Pathophysiology and CGRP Targeted Therapies - Grand Rounds SJHH

▶︎
Dr. Carrie Dougherty - What is CGRP?

▶︎
Rapid Fire Allergy Update

▶︎
COPD: A review of the latest changes in the 2024 GOLD COPD Evaluation & Treatment Guidelines

▶︎
Types of Headaches | Primary vs. Secondary | Migraine, Cluster, Tension Headaches

▶︎
Asthma 2024- The State of the State of Asthma: Guidelines and Changes

▶︎
Adverse Events of Anti-CGRP Monoclonal Antibodies for Migraine

▶︎
CNS Infections

▶︎
Neurology update: from headache to migraine. 10 April 2024. Chris O'Brien Lifehouse CPD series

▶︎
How to Stop Headaches Using Science-Based Approaches

▶︎
Migraine Treatment update - Mathew Robbins, MD

▶︎
COPD Committee Edition GOLD 2025 Update

▶︎
Differential Diagnosis for Continuous Daily Headache- Primary Headache Disorders- PART 1

▶︎
Day 2 Session 1 Diabetes

▶︎
Reduce MIGRAINE Headaches by 95% (4 Simple Steps) 2026

▶︎
Debate: Migraine Attacks are of Peripheral Origin | Drs. Thien P. Do & Anders Hougaard | ICAMS 2022

▶︎
The Functional Medicine Approach To Ending Migraines

▶︎
Multiple Sclerosis (MS) Treatment, Symptoms, Types, Pathophysiology, Medicine Lecture USMLE/NCLEX

▶︎
